| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,016,000 | 920,000 | 901,000 | 911,000 | | Cost of Revenue | 1,140,000 | (442,000) | 591,000 | 428,000 | | | Gross Profit | (124,000) | 1,362,000 | 310,000 | 483,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (377,000) | 1,165,000 | 135,000 | 294,000 | | Non Recurring |
-
| 3,000 | 43,000 | 1,471,000 | | Others | 46,000 | 45,000 | 43,000 | 47,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 207,000 | 149,000 | 89,000 | (1,329,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,000 | 3,000 | 4,000 | 6,000 | | Earnings Before Interest And Taxes | 209,000 | 152,000 | 93,000 | (1,323,000) | | Interest Expense | 34,000 | 26,000 | 19,000 | 21,000 | | Income Before Tax | 175,000 | 126,000 | 74,000 | (1,344,000) | | Income Tax Expense | 71,000 | 55,000 | 29,000 | 12,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 104,000 | 71,000 | 45,000 | (1,356,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 104,000 | 71,000 | 45,000 | (1,356,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $104,000 | $71,000 | $45,000 | ($1,356,000) |
|
0.51% Nasdaq 
0.13 (0.62%) 
Income Statement
